Nalmefene (intranasal)

nalmefene · Opiant Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nalmefene (intranasal), covering 2024-08-13 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacodynamic Evaluation of Intranasal Nalmefene [Phase 1]